Interleukin-3 as a Potential Bone Anabolic Agent in treating Postmenopausal Osteoporosis
Vikrant Piprode, Shubhanath Behera, Juilee Karhade, Garima Pandey, Arpita Prasad, Krishna Ezhuthachan, Mohan R. Wani
IL-3 treatment preserves trabecular bone architecture and enhances bone mineral density in ovariectomized mice, showing dual anti-osteoclastic and pro-osteoblastic effects in postmenopausal osteoporosis.
bioRxiv · Jul 12, 2025 · PreprintPathology